Every week we bring you the latest CEO, CFO, and director resignations and appointments across public companies.
Moves in This Issue
CEO: CSPR, DT, SIX, SPLK, TALK
CFO: BWXT, CCMP, INGR, PCT, PRLD, RMBS, SANW, TOI, TTEC
Directors: ALHC, AMZN, ANGI, AZEK, BGFV, BOLT, BRMK, CBRL, CMP, DCI, EAT, EPZM, FLXN, HLT, IMRA, LFMD, LOVE, MTOR, NOVT, NVST, OB, RGA, RGS, RMBL, SIX, SLM, SRNE, TALK, TMHC, TOI, TRIL, XFOR, XONE, XRX (and more)
CEO Resignations & Appointments
Casper Sleep Inc (CSPR)
Leaving: CEO – Philip Krim ( 8.1 yrs; -38.4% TSR)
Replaced by: Emilie Arel
With over 20 years of leadership experience across retail, merchandising, customer experience, and marketing, Emilie Arel has led Casper’s commercial and brand strategy. Previously, Emilie was the CEO of FULLBEAUTY Brands, a plus-size apparel company, where she led the company through a debt restructuring and put the company on the path to a digital transformation. Prior to that, she serv…read full bio
Dynatrace Inc (DT)
Leaving: CEO – John Van Siclen ( 13.9 yrs; 65.5% TSR)
Replaced by: Rick M McConnell
Prior to joining the Company, Mr. McConnell served as President of Akamai Technologies, Inc., and General Manager of its Security Technology Group since March 2021. From May 2016 through February 2021, he served as President and General Manager of Akamai’s Web Division. In addition, Mr. McConnell previously served as Akamai’s President – Products and Development from January 2…read full bio
Six Flags Entertainment Corp (SIX)
Leaving: CEO – Mike Spanos ( 2.0 yrs; -3.8% TSR)
Replaced by: Selim A Bassoul
Mr. Bassoul, age 64, has served as a director of the Company since February 2020 and served as non-executive Chairperson of the Board from February 2021 to November 14, 2021. Prior to joining the Company, Mr. Bassoul served as Chairman (from 2004 to 2019), President and Chief Executive Officer (from 2001 to 2019) of The Middleby Corporation, a manufacturer of food service and processing equipment….read full bio
Splunk Inc (SPLK)
Leaving: CEO – Doug Merritt ( 6.0 yrs; 18.9% TSR)
Replaced by: Graham Smith
Mr. Smith, age 61, has served as a member of our Board since 2011 and as Chair since 2019. Mr. Smith served in various leadership positions at salesforce.com, inc….read full bio
Talkspace Inc (TALK)
Leaving: CEO – Oren Frank ( .4 yrs; )
Replaced by (interim): Douglas L Braunstein
Mr. Braunstein, 60, has served as Chairman of the Board since June 22, 2021. Mr. Braunstein is the Founder and a Managing Partner of Hudson Executive Capital. Prior to founding Hudson Executive Capital, Mr. Braunstein was the C…read full bio
CFO Resignations & Appointments
BWX Technologies Inc (BWXT)
Leaving: CFO – David S Black ( 6.4 yrs; 9.3% TSR)
Replaced by: Robb A Lemasters
Mr. LeMasters’ promotion is part of the Company’s normal, enterprise-wide succession planning process. Mr. LeMasters has served as Senior Vice President and Chief Strategy Officer of the Company since July 2020. He previously served as a member of the Company’s Board of Directors and its Audit and Finance Committee from 2015 to 2020, as well as its Compensation Committee from 2017 to 2020. Prior t…read full bio
CMC Materials Inc (CCMP)
Leaving: CFO – Scott D Beamer ( 3.8 yrs; 11.6% TSR)
Replaced by: Jeanette A Press
Ms. Press, age 46, has served as the Company’s Principal Accounting Officer and Controller since June 2020, and prior to that as Vice President and Principal Accounting Officer, Univar Solutions, from 2019 to 2020, and Vice President, Controller and Principal Accounting Officer, USG Corporation, from 2014 to 2019. She holds a B.S. in Public Accounting from Loyola University, Chicago.read full bio
Oncology Institute Inc (TOI)
Leaving: CFO – Chris Wolfe ( 1.7 yrs; .1% TSR)
Replaced by: Scott Dalgleish
Scott Dalgleish has served as Chief Financial Officer of TOI since 2020. Prior to joining TOI, Mr. Dalgleish served as Chief Financial Officer of St. Joseph Heritage Health and Providence Health Network from 2018 to 2020, the Vice President of Finance for Concerto Health from 2017 to 2018 and Finance Director for DaVita from 2014 to 2017. Mr. Dalgleish h…read full bio
Prelude Therapeutics Inc (PRLD)
Leaving: CFO – Brian Piper ( 1.2 yrs; -34.4% TSR)
Replaced by: Laurent Chardonnet
Before joining the Company, Mr. Chardonnet, age 57, served as Senior Vice President and Chief Financial Officer of Axcella Health Inc. from November 2019 until November 2021. From 2004 to November 2019, Mr. Chardonnet served in various positions at Incyte Corporation, including Vice President, Treasurer and Principal Accounting Officer, Head of Finance and Administration for the Incyte’s …read full bio
PureCycle Technologies Inc (PCT)
Leaving: CFO – Michael E Dee ( 1.0 yrs; 26.9% TSR)
Replaced by: Lawrence C Somma
Mr. Somma most recently served as Vice President, Finance Strategy & Transformation, at LyondellBasell Industries N.V. since February 8, 2020. Mr. Somma previously served as LyondellBassell’s Vice President, Corporate Treasurer from October 2013 until February 2020. Mr. Somma previously was employed by Hyatt Hotels Corporation from 2008 through 2013, serving as Senior Vice President a…read full bio
Rambus Inc (RMBS)
Leaving: CFO – Rahul Mathur ( 5.1 yrs; 12.3% TSR)
Replaced by: Keith A Jones
Mr. Jones, age 50, currently serves as the Company’s Vice President, Chief Accounting Officer and Corporate Controller (Principal Accounting Officer) and has been in that role since February 2019. In addition, Mr. Jones served as the Vice President of Finance and Corporate Controller of the Company since February 2018. Previously, Mr. Jones served as Worldwide Corporate Controller, Vice P…read full bio
TTEC Holdings Inc (TTEC)
Leaving: CFO – Regina Paolillo ( 10.0 yrs; 20.3% TSR)
Replaced by: Dustin J Semach
Prior to joining TTEC in December 2020, Mr. Semach held several senior financial roles in the technology services and business process outsourcing industries, including chief financial officer of Rackspace Technology (NASDAQ: RXT), a clo…read full bio
Director Departures
Amazon Com Inc (AMZN)
Thomas O’Ryder ( 19.1 yrs; 31.6% TSR)
Committees: Audit, Leadership Development and Compensation
Angi Inc (ANGI)
Yilu Zhao ( 4.2 yrs; -.4% TSR)
Committees: Audit
AZEK Co Inc (AZEK)
Brian Klos ( 3.8 yrs; 18.9% TSR)
Committees: Compensation
BIG 5 SPORTING GOODS Corp (BGFV)
Sandra N Bane ( 19.4 yrs; 10.1% TSR)
Committees: Audit, Compensation, Nominating (and Governance)
Brinker International Inc (EAT)
George R Mrkonic Jr ( 6.0% TSR)
Committees: Compensation, Nominating (and Governance)
Broadmark Realty Capital Inc (BRMK)
Joseph L Schocken ( 2.0 yrs; 6.7% TSR)
Committees: Finance
Compass Minerals International Inc (CMP)
Richard S Grant ( 17.6 yrs; 12.5% TSR)
Committees: Audit, Compensation
Cracker Barrel Old Country Store Inc (CBRL)
Norman E Johnson ( 9.3 yrs; 13.2% TSR)
Committees: Audit, Executive, Nominating (and Governance)
Donaldson Co Inc (DCI)
Andrew Cecere ( 8.2 yrs; 8.2% TSR)
Committees: Audit
Envista Holdings Corp (NVST)
Teresa Gayle Sheppard ( 1.3 yrs; 60.0% TSR)
Committees: Audit, Compensation
Epizyme Inc (EPZM)
Andrew R Allen ( 7.6 yrs; -20.7% TSR)
Committees: Compensation
ExOne Co (XONE)
Bonnie K Wachtel ( 8.8 yrs; -1.3% TSR)
Committees: Audit, Compensation
ExOne Co (XONE)
William Frederick Strome ( 6.5 yrs; 7.8% TSR)
Committees: Audit, Compensation, Nominating (and Governance)
ExOne Co (XONE)
Gregory F Pashke ( 5.5 yrs; 11.3% TSR)
Committees: Audit, Nominating (and Governance)
ExOne Co (XONE)
Roger William Thiltgen ( 3.3 yrs; 43.1% TSR)
Committees: Compensation, Nominating (and Governance)
Flexion Therapeutics Inc (FLXN)
Alan Milinazzo ( 10.8 yrs; -6.5% TSR)
Committees: Compensation
Flexion Therapeutics Inc (FLXN)
C Ann Merrifield ( 7.4 yrs; -3.9% TSR)
Committees: Audit
Flexion Therapeutics Inc (FLXN)
Elizabeth Kwo ( 1.3 yrs; -22.1% TSR)
Committees: Nominating (and Governance)
Flexion Therapeutics Inc (FLXN)
Heath Lukatch ( 9.8 yrs; -6.5% TSR)
Committees: Compensation
Flexion Therapeutics Inc (FLXN)
Mark Stejbach ( 5.2 yrs; -11.3% TSR)
Committees: Audit
Flexion Therapeutics Inc (FLXN)
Patrick J Mahaffy ( 12.8 yrs; -6.5% TSR)
Committees: Compensation, Nominating (and Governance)
Flexion Therapeutics Inc (FLXN)
Samuel D Colella ( 13.8 yrs; -6.5% TSR)
Committees: Compensation, Nominating (and Governance)
Flexion Therapeutics Inc (FLXN)
Scott A Canute ( 6.7 yrs; -11.9% TSR)
Committees: Nominating (and Governance)
Hilton Worldwide Holdings Inc (HLT)
John Schreiber ( 8.0 yrs; 16.2% TSR)
Committees: Compensation
IMARA Inc (IMRA)
Sara M Nayeem ( 5.8 yrs; -58.6% TSR)
Committees: Audit
Lovesac Co (LOVE)
Mary Fox ( 1.8 yrs; 163.6% TSR)
Committees: Audit, Compensation, Nominating (and Governance)
Novanta Inc (NOVT)
Deborah Disanzo ( 2.8 yrs; 30.0% TSR)
Committees: Environmental, Social and Governance
Regis Corp (RGS)
Daniel Gordon Beltzman ( 9.3 yrs; -17.1% TSR)
Committees: Compensation, Nominating (and Governance), Technology
Reinsurance Group Of America Inc (RGA)
Christine Rose Detrick ( 8.3 yrs; 7.4% TSR)
Committees: Compensation, Nominating (and Governance)
RumbleOn Inc (RMBL)
Richard A Gray Jr ( 4.1 yrs; -17.9% TSR)
Committees: Audit, Compensation, Nominating (and Governance)
Six Flags Entertainment Corp (SIX)
Mike Spanos ( 2.1 yrs; -9.3% TSR)
Committees: Nominating (and Governance)
SLM Corp (SLM)
William N Shiebler ( 7.6 yrs; -3.4% TSR)
Committees: Compensation, Nominating (and Governance), Preferred Stock, Strategic Planning
Taylor Morrison Home Corp (TMHC)
Jeffry L Flake ( 2.8 yrs; 21.5% TSR)
Committees: Nominating (and Governance)
Directors Joining
Adicet Bio Inc (ACET)
Michael Kauffman
Dr. Kauffman joins the Adicet board with over 20 years of experience in the life sciences industry, including expertise in preclinical research, clinical development and regulatory strategy. Currently, he is a board member for Karyopharm Therapeutics, Verastem Oncology and Kezar Life Scienc…read full bio
Aligos Therapeutics Inc (ALGS)
Bridget A Martell
Dr. Martell is an accomplished physician and biopharmaceutical executive who currently holds several executive and advisory roles, including as the President and CEO of Artizan Biosciences, a precision medicine microbiome company, a member of the Board of Directors at Achieve Life Sciences, and a…read full bio
AZEK Co Inc (AZEK)
Vernon J Nagel
Mr. Nagel is a seasoned executive having provided products and services to the residential and non-residential construction markets while he served as the executive chairman of the board of directors of Acuity Brands, Inc., or Acuity Brands, from February 2020 to the end of 2020, and, previously, as…read full bio
Brain Scientific Inc (BRSF)
Donald S Mackenzie
Donald MacKenzie, with over 30 years as a co-founder and senior managing director of Conway MacKenzie, Inc., is a recognized expert at orchestrating successful financial and operational restructuring and turnaround transactions. He also has a proven track record guiding successful mergers and acq…read full bio
Brighthouse Financial Inc (BHF)
Carol Juel
Ms. Juel is currently executive vice president, chief technology and operating officer of Synchrony Financial. Prior to her current role, she served as Synchrony’s chief information officer from 2014 to June 2021. Prior to Synchrony, she served as chief information officer of GE Cap…read full bio
Embark Technology Inc (EMBK)
Brandon Moak
Brandon Moak. Brandon Moak co-founded Embark and has served as Embark’s Chief Technology Officer since the company’s founding in 2016. In his role, he leads engineering and R&D at our company, and has overseen development of the Embark Driver softw…read full bio
Epizyme Inc (EPZM)
Carol Stuckley
Carol Stuckley, M.B.A., is a finance executive with significant experience leading the financial aspects of large global healthcare companies. Ms. Stuckley spent more than 22 years at Pfizer, Inc. in a variety of global financial roles of increasing responsibility, mos…read full bio
Epizyme Inc (EPZM)
Roy A Beveridge
Roy A. Beveridge, M.D., is a medical oncologist who has been in practice for more than 30 years during which time he has treated hundreds of lymphoma and myeloma patients. He has led large integrated provider networks and has deep expertise in healthcare policy and reimbursement. Previously, Dr.&…read full bio
Farmland Partners Inc (FPI)
Murray R Wise
Murray R. Wise was the founder of Westchester Group (currently the world’s largest institutional farmland asset manager) and started MWA as the spinoff of Westchester Group’s brokerage, auction and farm management business when the company was acquired by TIAA in 2010. Throughout his …read full bio
HomeTrust Bancshares Inc (HTBI)
Hunter Westbrook
Mr. Westbrook joined HomeTrust Bank in June 2012 as Senior Vice President and Chief Banking Officer. He began his career in banking with TCF Bank in Minneapolis and later joined TCF National Bank Illinois as Senior Vice President of Finance. In 2004 he was promoted to Executive…read full bio
ImmunoGen Inc (IMGN)
Tracey L McCain
Ms. McCain has served as Executive Vice President and Chief Legal and Compliance Officer of Blueprint Medicine Corporation, or Blueprint, a biotechnology company. Prior to Blueprint, from January 2016 to September 2016, Ms. McCain was Senior Vice President and Head of Legal fo…read full bio
Kala Pharmaceuticals Inc (KALA)
Mark S Blumenkranz
Dr. Blumenkranz has served as the HJ Smead Professor Emeritus of the Ophthalmic Innovation Program at the Byers Eye Institute at Stanford University since March 2019, and he previously served as HJ Smead Professor and Chairman of the Byers Eye Institute from September 1997 to August 2015 and as H…read full bio
Longboard Pharmaceuticals Inc (LBPH)
Jane Tiller
Dr. Tiller currently serves as Chief Medical Officer of Neumora Therapeutics, a position she has held since Neumora acquired BlackThorn Therapeutics, where she had served as Chief Medical Officer. Prior to BlackThorn, Dr. Tiller was Head of Medical European Markets, Australia and …read full bio
Markel Corp (MKL)
Morgan E Housel
Housel serves as a partner of The Collaborative Fund, a multi-stage private investment fund. He is also a frequent presenter discussing matters related to risk, investor psychology and business history, and author of the book The Psychology of Money.Pri…read full bio
Proto Labs Inc (PRLB)
Stacy Greiner
Ms. Greiner serves as the General Manager, North America Sales & Marketing Business for Dun & Bradstreet, a leading global provider of business decisioning data and analytics. Ms. Greiner has significant expertise in general management, digital marketing, and data analytics. Prior to her current pos…read full bio
Rani Therapeutics Holdings Inc (RANI)
Lyn Baranowski
Lyn Baranowski has 18 years’ experience building, directing and guiding biopharmaceutical companies. Currently, Ms. Baranowski serves as the Chief Operating Officer at Altavant Sciences, a clinical stage biopharmaceutical company focused on rare respiratory diseases. Prior to Altavant, Ms. …read full bio
Siebert Financial Corp (SIEB)
Cynthia DiBartolo
Ms. DiBartolo has been appointed to and serves on a number of boards in relation to her personal and professional career including but not limited to: Chairperson of the Rainbow PUSH Coalition Steering Committee for Financial Services; Founder & Chairperson of the Diversity Broker-Dealer & Asset Man…read full bio
Sorrento Therapeutics Inc (SRNE)
Elizabeth Czerepak
Elizabeth A. Czerepak has over 35 years of experience in big pharma, biotechnology and venture capital and has served as the Chief Financial Officer of BeyondSpring Inc. (Nasdaq: BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies…read full bio
Spire Global Inc (SPIR)
Dirk Hoke
Mr. Hoke was most recently Chief Executive Officer of the Airbus Defence and Space division of Airbus SE and served as a member of the Airbus Executive Committee. Before joining Airbus, he worked at Siemens AG, where he held various executive-level positions including General Manager for the…read full bio
Spire Global Inc (SPIR)
Dirk Hoke
Mr. Hoke was most recently Chief Executive Officer of the Airbus Defence and Space division of Airbus SE and served as a member of the Airbus Executive Committee. Before joining Airbus, he worked at Siemens AG, where he held various executive-level positions including General Manager for the…read full bio
Verastem Inc (VSTM)
Michelle Robertson
Prior to joining Editas Medicine, Ms. Robertson served as Chief Financial Officer of Momenta Pharmaceuticals, Inc. prior to its acquisition by Johnson & Johnson in 2020. She joined Momenta as Vice President, Financial Planning and Analysis. Previously, she served as Vice President, Oncology F…read full bio
About Boardroom Alpha
Boardroom Alpha provides ratings, analytics, and context on US public company directors, CEOs, and CFOs. Learn more at staging-boardroomalpha.temp312.kinsta.cloud.